New Director Shifts Balance Of Power At Livermore Lab

LIVERMORE, CALIF.-Last summer Edward Teller, founder of the Lawrence Livermore National Laboratory, took his protégé, Livermore theoretical physicist Lowell Wood, to the White House. There they met with President Ronald Reagan and Vice President George Bush to discuss Wood's latest idea for a weapon to defend the country against incoming Soviet missiles. Joining them was John Nuckolls, a nuclear physicist who a few months earlier had become the director of Livermore, the Department of

Written byTa Heppenheimer
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Today, a year later, the fate of the Strategic Defense Initiative (SDI)-and with it the "Brilliant Pebbles" approach that Wood has proposed-remains an open question, as Congress debates whether the country needs and can afford such a military system. But many scientists say that the July 1988 meeting in the White House was much more than a technical briefing on Wood's idea for a lightweight, computer-driven, high-speed projectile to help defend the country. Nuckolls' presence at the meeting, they worry, was intended as an endorsement of a heightened political role for the 37-year-old laboratory-change that could jeopardize the lab's reputation for high-quality science and its ability to attract brilliant young talent. Such a role would also upset the traditional balance between those who advocate exotic new weapons systems and those who favor gradual improvements in existing hardware by giving the upper hand to the visionaries.

In addition, critics fear that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies